Risk and survival of patients with medullary thyroid cancer: National perspective

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor that accounts for 1% –2% of thyroid cancers in the United States [1]. MTC derives from the neuroendocrine parafollicular calcitonin-producing (C) cells of the thyroid [2]. Sporadic MTC accounts for the majority of MTC, approximately 80%, while the remaining presents as part of inherited tumor syndromes, such as multip le endocrine neoplasia type 2A and 2B, or familial MTC [2].

Source: Oral Oncology - June 12, 2018 Category: Cancer & Oncology Authors: Zaid Al-Qurayshi, Helmi Khadra, Kristi Chang, Nitin Pagedar, Gregory W. Randolph, Emad Kandil Source Type: research